APPLICATION
NDA009660
TYPE
NDA
ORIGINAL APPROVAL
1955-01-18
LATEST ACTION
1996-04-26
ROUTE
ORAL
DOSAGE FORM
ELIXIR, CAPSULE, TABLET
MARKETING STATUS
Discontinued
Products
NOLUDARDiscontinued
METHYPRYLON 50MG/5ML · ELIXIR · ORAL
NOLUDARDiscontinued
METHYPRYLON 300MG · CAPSULE · ORAL
NOLUDARDiscontinued
METHYPRYLON 200MG · TABLET · ORAL
NOLUDARDiscontinued
METHYPRYLON 50MG · TABLET · ORAL
Approval history
1996-04-26Labeling · Supplement 9AP
1986-08-27Labeling · Supplement 16AP
1982-02-26Labeling · Supplement 14AP
1980-12-15Labeling · Supplement 13AP
1979-03-21Labeling · Supplement 12AP
1978-10-27Labeling · Supplement 10AP
1977-06-23Labeling · Supplement 8AP
1977-06-23Labeling · Supplement 7AP
1955-01-18Type 1 - New Molecular Entity · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.